I agree that this site is using cookies. You can find further informations here.
X
Bonneville-levard, A
40  results:
Search for persons X
?
1

KS02.4.A Olaparib in Recurrent IDH-mutant High-Grade Glioma..:

Ducray, F ; Sanson, M ; Chinot, O...
Neuro-Oncology.  23 (2021)  Supplement_2 - p. ii4-ii4 , 2021
Link: https://doi.org/10.1093/..
 
?
2

Immune checkpoint inhibitor treatment of a first cancer is ..:

Heudel, P. ; Chabaud, S. ; Perol, D....
ESMO Open.  6 (2021)  1 - p. 100044 , 2021
Link: https://doi.org/10.1016/..
 
?
3

Assessment of Karnofsky (KPS) and WHO (WHO-PS) performance ..:

Frappaz, D. ; Bonneville-Levard, A. ; Ricard, D....
Supportive Care in Cancer.  29 (2020)  4 - p. 1883-1891 , 2020
Link: https://doi.org/10.1007/..
 
?
4

P14.04 10 years of weekly web conference for brain tumor of..:

Frappaz, D ; Bronnimann, C ; Faure Conter, C...
Neuro-Oncology.  21 (2019)  Supplement_3 - p. iii67-iii67 , 2019
Link: https://doi.org/10.1093/..
 
?
5

P14.127 From next generation sequencing and comparative gen..:

Bonneville-levard, A ; Frappaz, D ; Pissaloux, D...
Neuro-Oncology.  21 (2019)  Supplement_3 - p. iii99-iii99 , 2019
Link: https://doi.org/10.1093/..
 
?
6

OS4.1 MEVITEM: A European, randomized, open-label, Phase I/..:

Frappaz, D ; Barritault, M ; Montané, L...
Neuro-Oncology.  21 (2019)  Supplement_3 - p. iii10-iii10 , 2019
Link: https://doi.org/10.1093/..
 
?
7

PL3.2 Trabectedin for recurrent WHO grade II or III meningi..:

Preusser, M ; Silvani, A ; Le Rhun, E...
Neuro-Oncology.  21 (2019)  Supplement_3 - p. iii2-iii3 , 2019
Link: https://doi.org/10.1093/..
 
?
8

P20.01 MEVITEM: A European, randomized, open-label Phase I/..:

Frappaz, D. ; Meyronnet, D. ; Garin, G....
Neuro-Oncology.  18 (2016)  suppl_4 - p. iv80-iv80 , 2016
Link: https://doi.org/10.1093/..
 
?
9

Intensive pediatric chemotherapy regimen (PNET HR+5) in adu..:

Larrouquere, Louis ; Dufour, Christelle ; Faure-Conter, Cécile...
Neuro-Oncology Advances.  , 2024
Link: https://doi.org/10.1093/..
 
?
10

Olaparib in recurrent isocitrate dehydrogenase mutant high-..:

Esparragosa Vazquez, Ines ; Sanson, Marc ; Chinot, Olivier L...
Neuro-Oncology Advances.  6 (2024)  1 - p. , 2024
Link: https://doi.org/10.1093/..
 
?
11

Trabectedin for recurrent WHO grade 2 or 3 meningioma: A ra..:

Preusser, Matthias ; Silvani, Antonio ; Le Rhun, Emilie...
Neuro-Oncology.  24 (2021)  5 - p. 755-767 , 2021
Link: https://doi.org/10.1093/..
 
?
12

MEVITEM—a phase I/II trial of vismodegib + temozolomide vs ..:

Frappaz, Didier ; Barritault, Marc ; Montané, Laure...
Neuro-Oncology.  23 (2021)  11 - p. 1949-1960 , 2021
Link: https://doi.org/10.1093/..
 
?
13

Molecular profile to guide personalized medicine in adult p..:

Bonneville-Levard, Alice ; Frappaz, Didier ; Tredan, Olivier...
Medical Oncology.  39 (2021)  1 - p. , 2021
Link: https://doi.org/10.1007/..
 
?
14

Skull vault hemangioma mimicking neoplastic lesion on [68Ga..:

Moreau, Aurélie ; Marie, Edouard ; Bonneville-Levard, Alice..
Radiology Case Reports.  15 (2020)  12 - p. 2598-2601 , 2020
Link: https://doi.org/10.1016/..
 
?
15

Reduced-dose craniospinal irradiation is feasible for stand..:

Massimino, Maura ; Sunyach, Marie Pierre ; Barretta, Francesco...
Journal of Neuro-Oncology.  148 (2020)  3 - p. 619-628 , 2020
Link: https://doi.org/10.1007/..
 
1-15